Experimental Drug ZMapp May Have Saved Ebola Victims

The experimental drug from Mapp Biopharmaceutical Inc. had never been tried before in humans, but had shown promise in small experiments with monkeys

Aug. 6, 2014

According to a CNN report, Dr. Kent Brantly thought he was going to die. After nine days since the American missionary worker came down with Ebola in Liberia, his condition was worsening by the minute.

Brantly is on the mend after receiving a last-ditch experimental drug. Another American missionary with Ebola received the same. Brantly's and Nancy Writebol's conditions significantly improved after receiving the medication, sources say. Read the full story